LNCARSR and hepatocellular carcinoma: For example, lncARSR is up‐regulated in HCC and lncARSR overexpression enhances the doxorubicin resistance of HCC cells via modulating PTEN‐PI3K/Akt pathway in vitro and in vivo.10